Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 3.3mm NC, SLActive 8mm, TiZr, NTP: medical device reports filed with FDA

2,694 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

2,694
device reports naming the brand
0% of all MAUDE reports · about 395 a year
325
reports, 12 months to August 2026
436 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 2,694 reports that name the brand "BL, ? 3.3mm NC, SLActive 8mm, TiZr, NTP" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

325 reports arrived in the 12 months to August 2026, down 25% from 436 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (61.4%), loss of osseointegration (33.7%) and fracture (2.3%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

04284Sep 2021: 30Oct 2021: 39Nov 2021: 43Dec 2021: 202022Jan 2022: 33Feb 2022: 21Mar 2022: 19Apr 2022: 43May 2022: 30Jun 2022: 21Jul 2022: 34Aug 2022: 41Sep 2022: 35Oct 2022: 35Nov 2022: 17Dec 2022: 442023Jan 2023: 34Feb 2023: 34Mar 2023: 18Apr 2023: 36May 2023: 33Jun 2023: 25Jul 2023: 27Aug 2023: 25Sep 2023: 40Oct 2023: 42Nov 2023: 29Dec 2023: 392024Jan 2024: 35Feb 2024: 37Mar 2024: 22Apr 2024: 56May 2024: 35Jun 2024: 27Jul 2024: 31Aug 2024: 35Sep 2024: 38Oct 2024: 48Nov 2024: 41Dec 2024: 312025Jan 2025: 42Feb 2025: 37Mar 2025: 26Apr 2025: 20May 2025: 0Jun 2025: 84Jul 2025: 34Aug 2025: 35Sep 2025: 24Oct 2025: 28Nov 2025: 18Dec 2025: 482026Jan 2026: 23Feb 2026: 28Mar 2026: 37Apr 2026: 22May 2026: 30Jun 2026: 20Jul 2026: 18Aug 2026: 29

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02184362019: 22320192020: 31320202021: 36420212022: 37320222023: 38220232024: 43620242025: 39620252026: 2072026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,694
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report89.7%2,416
Voluntary report0%0
User facility report0%0
Distributor report10.3%278
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,65361.4%62.8%
Loss of osseointegration90733.7%22.4%
Fracturea broken bone622.3%1.6%
Difficult to insertthe device was hard to insert100.4%0.4%
Unintended movement40.1%0%
Separation failure10%0.1%
Therapeutic or diagnostic output failure10%0%
Unstable10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis78429.1%
Painpain, site not specified49618.4%
Tissue damage34612.8%
Inflammationinflammation2238.3%
Hemorrhage/blood loss/bleeding1696.3%
Swelling/ edema1505.6%
Fistula813%
Abscessa collection of pus602.2%
Hyperresponsive to stimuli481.8%
Hypersensitivity/allergic reaction321.2%
Failure of implant240.9%
Swellingswelling210.8%
Inadequate osseointegration110.4%
Sinus perforation110.4%
Numbnessnumbness80.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 3.3mm NC, SLActive 8mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports2,6943,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer89.7%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 3.3mm NC, SLActive 8mm, TiZr, NTP reports

How many FDA reports name BL, ? 3.3mm NC, SLActive 8mm, TiZr, NTP?

2,694 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 325 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (61.4%), loss of osseointegration (33.7%), fracture (2.3%), difficult to insert (0.4%) and unintended movement (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (89.7%) and distributor reports (10.3%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 3.3mm NC, SLActive 8mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.